Skip to main content
ABCL
NASDAQ Life Sciences

AbCellera Inks Jazz Pharma Deal: $56M Upfront, Potential $792M Per Program in Milestones

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$5.13
Mkt Cap
$1.554B
52W Low
$2.745
52W High
$6.79
52W Position info
87% above low
Off High info
24% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ABCL sits 87% above its 52-week low of $2.745.

Summary

AbCellera announced a significant collaboration with Jazz Pharmaceuticals to discover next-generation T-cell engaging multispecific antibodies for various cancers. AbCellera will receive $56 million upfront for two initial programs, with an additional $28 million due upon starting a third. Critically, the deal includes potential milestone payments of up to $792 million per program plus tiered royalties, offering substantial long-term revenue upside. This partnership provides immediate financial strength and validates AbCellera's discovery platform, materially de-risking its pipeline.

At the time of this announcement, ABCL was trading at $5.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $2.75 to $6.79. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

ABCL - Latest Insights

ABCL
Nov 09, 2026, 4:22 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.54
Real-time Price: $12.89 info
Change: +$0.348 (+3%) info
Market Cap: $4.051B info
ABCL
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $12.90
Real-time Price: $12.89 info
Change: -$0.0100 (-0.08%) info
Market Cap: $4.051B info
ABCL
Aug 13, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.97
Real-time Price: $12.89 info
Change: +$1.92 (+18%) info
Market Cap: $4.051B info
ABCL
Aug 13, 2026, 12:05 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $10.32
Real-time Price: $12.89 info
Change: +$2.57 (+25%) info
Market Cap: $4.051B info
ABCL
Aug 11, 2026, 4:59 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $9.32
Real-time Price: $12.89 info
Change: +$3.57 (+38%) info
Market Cap: $4.051B info